Consensus Stryker Corporation

Stocks

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 21:01:09 08/10/2026 BST			5-day change	1st Jan Change
276.97 ^USD	+0.57%		+1.47%	-21.20%

10-06	Stryker Corporation Announces CEO Changes, Effective January 1, 2027	CI
10-06	Stryker Corporation Announces Management Changes, Effective January 1, 2027	CI

Evolution of the Average Target: Stryker Corporation

Evolution of the Target Price: Stryker Corporation

Changes in Analyst Recommendations: Stryker Corporation

519c7550fb6f2a066.cP17eVOe27M7SM6zK_uEXZvE142izpSwtKM6XCymOTI.Fb8OQRL17_hhO6jeUb_xbe2wvtqQmMDmw9YJaEvKfUobsDkDNdG6wV8Z9g~7150e1f25f34cf6b84098a0e204e5fd2

Analysts' recommendations: Stryker Corporation

10-06	Truist Securities Cuts Stryker Price Target to $310 From $340, Maintains Hold Rating	MT
10-06	Evercore ISI Adjusts Price Target on Stryker to $335 From $355, Keeps Outperform Rating	MT
10-06	Evercore ISI Adjusts Stryker Price Target to $335 From $355, Maintains Outperform Rating	MT
09-30	Stifel Adjusts Price Target on Stryker to $330 From $360, Maintains Buy Rating	MT
09-22	TD Cowen Adjusts Price Target on Stryker to $298 From $355, Keeps Hold Rating	MT
09-22	Jefferies Adjusts Price Target on Stryker to $405 From $440, Keeps Buy Rating	MT
09-21	Raymond James Adjusts Price Target on Stryker to $330 From $370, Keeps Outperform Rating	MT
09-18	Canaccord Genuity Adjusts Price Target on Stryker to $385 From $400, Keeps Buy Rating	MT
09-17	Stryker Facing Promising Setup Next Year, Trading Upside Limited in 2026, RBC Says	MT
09-14	Bernstein Adjusts Price Target on Stryker to $385 From $420, Keeps Outperform Rating	MT
09-09	Citigroup Adjusts Stryker Price Target to $360 From $399, Maintains Buy Rating	MT
09-09	Wells Fargo Adjusts Price Target on Stryker to $348 From $418, Keeps Overweight Rating	MT
09-09	BMO Capital Adjusts Price Target on Stryker to $317 From $369, Keeps Outperform Rating	MT
08-18	Leerink Partners Adjusts Price Target on Stryker to $403 From $407, Maintains Outperform Rating	MT
08-13	Citigroup Adjusts Price Target on Stryker to $399 From $385, Maintains Buy Rating	MT
08-05	Rothschild & Co Redburn Adjusts Stryker Price Target to $360 From $346	MT
08-03	UBS Adjusts Stryker Price Target to $382 From $400, Maintains Buy Rating	MT
08-03	Analyst recommendations: Chevron, Linde, RTX, Colgate-Palmolive, American Electric Power...
07-31	RBC Cuts Price Target on Stryker to $420 From $435, Keeps Outperform Rating	MT
07-31	Evercore ISI Adjusts Stryker Price Target to $355 From $350, Maintains Outperform Rating	MT
07-31	Truist Lifts Price Target on Stryker to $340 From $330, Keeps Hold Rating	MT
07-31	Raymond James Adjusts Price Target on Stryker to $370 From $383, Maintains Outperform Rating	MT
07-31	Jefferies Adjusts Price Target on Stryker to $440 From $455, Maintains Buy Rating	MT
07-31	BTIG Adjusts Price Target on Stryker to $358 From $371, Maintains Buy Rating	MT
07-31	Piper Sandler Adjusts Price Target on Stryker to $390 From $420, Maintains Overweight Rating	MT

More recommendations

Medical Devices & Implants

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	STRYKER CORPORATION					+32.95%
	ABBOTT LABORATORIES					+22.27%
	MEDTRONIC PLC					+22.14%
	ESSILORLUXOTTICA					+55%
	CENCORA, INC.					+16.6%
	HOYA CORPORATION					+20.15%
	BECTON, DICKINSON AND COMPANY					+7.72%
	IDEXX LABORATORIES, INC.					+38.42%
	DEXCOM, INC.					+14.15%
	MEDLINE INC.					+25.53%
	Average					+25.49%
	Weighted average by Cap.					+26.26%